Elimination of immune responses to viral vectors

Details for Australian Patent Application No. 2009214038 (hide)

Owner Life Sciences Research Partners vzw

Inventors Saint-Remy, Jean-Marie

Agent Spruson & Ferguson

Pub. Number AU-A-2009214038

PCT Pub. Number WO2009/101204

Priority 08447008.7 14.02.08 EP; 61/035,826 12.03.08 US

Filing date 16 February 2009

Wipo publication date 20 August 2009

International Classifications

C07K 14/075 (2006.01) Peptides having more than 20 amino acids

A61K 39/12 (2006.01) Medicinal preparations containing antigens or antibodies - Viral antigens

A61K 39/39 (2006.01) Medicinal preparations containing antigens or antibodies - characterised by the immunostimulating additives, e.g. chemical adjuvants

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

C12N 9/02 (2006.01) Enzymes, e.g. ligases (6.) - Oxidoreductases (1.), e.g. luciferase

C12N 15/86 (2006.01) Mutation or genetic engineering - Viral vectors

Event Publications

2 September 2010 PCT application entered the National Phase

  PCT publication WO2009/101204 Priority application(s): WO2009/101204

29 March 2012 Assignment before Grant

  Life Sciences Research Partners vzw The application has been assigned to Katholieke Universiteit Leuven, K.U.Leuven R&D; Life Sciences Research Partners vzw

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009214039-Immunogenic control of tumours and tumour cells

2009214036-System, ophthalmic lens, and method for extending depth of focus